Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Armandi

Showing results (71-80 of 122) with videos related to

Pageof 13
Sort By:
Journal of Clinical Medicine|July 29, 2020
Clinical Response and Changes of Cytokines and Zonulin Levels in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Treated with <i>Bifidobacterium Longum</i> ES1 for 8 or 12 Weeks: A Preliminary ReportGian Paolo Caviglia, Alessandra Tucci, Rinaldo Pellicano, et al.
Biology|April 3, 2021
The Clinical Role of Serum Epidermal Growth Factor Receptor 3 in Hepatitis C Virus-Infected Patients with Early Hepatocellular CarcinomaGian Paolo Caviglia, Maria Lorena Abate, Emanuela Rolle, et al.
JHEP Reports : Innovation in Hepatology|June 22, 2026
Impact of weight loss and reduction of ultra-processed foods on liver fat content in MASLD: a randomized controlled trialSimona Bo, Angelo Armandi, Gabriele Castelnuovo, et al.
Cancers|March 29, 2023
Prognostic Value of Simple Non-Invasive Tests for the Risk Stratification of Incident Hepatocellular Carcinoma in Cirrhotic Individuals with Non-Alcoholic Fatty Liver DiseaseAngelo Armandi, Gian Paolo Caviglia, Amina Abdulle, et al.
Journal of Clinical Medicine|December 17, 2024
Associations Between Polymorphisms of Genes Related to Vitamin D Pathway and the Response to Vedolizumab and Ustekinumab in Inflammatory Bowel DiseaseJessica Cusato, Davide Giuseppe Ribaldone, Antonio D Avolio, et al.
European Journal of Internal Medicine|January 21, 2022
Derivation and validation of the nonalcoholic fatty liver disease cirrhosis score (NCS) to distinguish bridging fibrosis from cirrhosisChristian Labenz, Gerrit Toenges, Ming-Hua Zheng, et al.
European Radiology Experimental|December 12, 2023
Variability of transient elastography-based spleen stiffness performed at 100 HzAngelo Armandi, Talal Merizian, Merle Marie Werner, et al.
Journal of Crohn'S & Colitis|February 23, 2023
Non-hepatic Solid Organ Transplant in Patients with Inflammatory Bowel Disease: An ECCO CONFER Multicentre Case SeriesDavide Giuseppe Ribaldone, Sophie Vieujean, Mette Julsgaard, et al.
Alimentary Pharmacology & Therapeutics|April 10, 2025
Extracellular Vesicles miRNome Profiling Reveals miRNAs Engagement in Dysfunctional Lipid Metabolism, Chronic Inflammation and Liver Damage in Subjects With Metabolic Dysfunction-Associated Steatotic Liver DiseaseGian Paolo Caviglia, Elisabetta Casalone, Chiara Rosso, et al.
Cancers|June 2, 2021
Biomarkers of Oncogenesis, Adipose Tissue Dysfunction and Systemic Inflammation for the Detection of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver DiseaseGian Paolo Caviglia, Angelo Armandi, Chiara Rosso, et al.
Pageof 13

Showing results (71-80 of 122) with videos related to

Sort By:
Pageof 13
Journal of Clinical Medicine|July 29, 2020
Clinical Response and Changes of Cytokines and Zonulin Levels in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Treated with <i>Bifidobacterium Longum</i> ES1 for 8 or 12 Weeks: A Preliminary ReportGian Paolo Caviglia, Alessandra Tucci, Rinaldo Pellicano, et al.
Biology|April 3, 2021
The Clinical Role of Serum Epidermal Growth Factor Receptor 3 in Hepatitis C Virus-Infected Patients with Early Hepatocellular CarcinomaGian Paolo Caviglia, Maria Lorena Abate, Emanuela Rolle, et al.
JHEP Reports : Innovation in Hepatology|June 22, 2026
Impact of weight loss and reduction of ultra-processed foods on liver fat content in MASLD: a randomized controlled trialSimona Bo, Angelo Armandi, Gabriele Castelnuovo, et al.
Cancers|March 29, 2023
Prognostic Value of Simple Non-Invasive Tests for the Risk Stratification of Incident Hepatocellular Carcinoma in Cirrhotic Individuals with Non-Alcoholic Fatty Liver DiseaseAngelo Armandi, Gian Paolo Caviglia, Amina Abdulle, et al.
Journal of Clinical Medicine|December 17, 2024
Associations Between Polymorphisms of Genes Related to Vitamin D Pathway and the Response to Vedolizumab and Ustekinumab in Inflammatory Bowel DiseaseJessica Cusato, Davide Giuseppe Ribaldone, Antonio D Avolio, et al.
European Journal of Internal Medicine|January 21, 2022
Derivation and validation of the nonalcoholic fatty liver disease cirrhosis score (NCS) to distinguish bridging fibrosis from cirrhosisChristian Labenz, Gerrit Toenges, Ming-Hua Zheng, et al.
European Radiology Experimental|December 12, 2023
Variability of transient elastography-based spleen stiffness performed at 100 HzAngelo Armandi, Talal Merizian, Merle Marie Werner, et al.
Journal of Crohn'S & Colitis|February 23, 2023
Non-hepatic Solid Organ Transplant in Patients with Inflammatory Bowel Disease: An ECCO CONFER Multicentre Case SeriesDavide Giuseppe Ribaldone, Sophie Vieujean, Mette Julsgaard, et al.
Alimentary Pharmacology & Therapeutics|April 10, 2025
Extracellular Vesicles miRNome Profiling Reveals miRNAs Engagement in Dysfunctional Lipid Metabolism, Chronic Inflammation and Liver Damage in Subjects With Metabolic Dysfunction-Associated Steatotic Liver DiseaseGian Paolo Caviglia, Elisabetta Casalone, Chiara Rosso, et al.
Cancers|June 2, 2021
Biomarkers of Oncogenesis, Adipose Tissue Dysfunction and Systemic Inflammation for the Detection of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver DiseaseGian Paolo Caviglia, Angelo Armandi, Chiara Rosso, et al.
Pageof 13